AIDS Advocates Push U.S. To Spend 50% Of Funds On Treatment
This article was originally published in PharmAsia News
Advocates also are not sure whether to push for a long-term PEPFAR reauthorization; the U.S. expects to release a PEPFAR spending blueprint along with future goals shortly.
You may also be interested in...
White House sends out short press release as FDA is conducting an unrelated briefing to announce the user fee bill was enacted, surprising stakeholders and generating political questions.
The new bill includes a provision requiring FDA to consider foreign clinical trial data when making approval decisions and more patient participation in drug development meetings. A cloture vote could come as soon as May 17 with floor debate possibly beginning next week, Sen. Reid says.
The group is afraid asking for wholesale changes to the law would invite too many problems, VP Dorman says at BIO.